Pelthos Therapeutics (PTHS) Proxy filing summary

Executive summary

• Annual meeting scheduled for September 29, 2026, with virtual participation available.

• Shareholders are encouraged to review proxy materials online or request paper/email copies before voting.

Voting matters and shareholder proposals

• Election of eight directors to serve until the next annual meeting or until successors are appointed.

• Ratification of Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026.

• Approval of the 2026 Equity Incentive Plan.

• Proxy may vote on other business that arises at the meeting.

Board of directors and corporate governance

• Eight nominees listed for board election, including Peter Greenleaf, Richard Baxter, Todd Davis, Andrew Einhorn, Ezra Friedberg, Dr. Richard Malamut, Matthew Pauls, and Scott Plesha.